International Companies

Eli Lilly's quarterly numbers disappoint, shares tumble

By Abigail Townsend

Date: Wednesday 30 Oct 2024

(Sharecast News) - Shares in Eli Lilly & Co fell sharply on Wednesday, after the US drugs firm missed quarterly forecasts and cut its full-year outlook.
The firm, which makes blockbuster weight-loss drug Zepbound, said third-quarter revenues rose 20% to $11.4bn.

That was driven by a 15% increase in volume...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page